Portfolio (Quarterly)
Guide ↗
Aisling Capital Management LP
· CIK 0001766721| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BBIO | BridgeBio Pharma Inc. (BBIO) | Healthcare | 5,089,611.0 | $378.0M | 79.35% | — | — | $74.26 | -10.7% |
| 2 | SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | Healthcare | 1,316,806.0 | $30.8M | 6.46% | — | — | $23.36 | -23.1% |
| 3 | GLUE | Monte Rosa Therapeutics Inc (GLUE) | Healthcare | 1,555,664.0 | $25.6M | 5.37% | +83K | +5.7% | $16.45 | -28.8% |
| 4 | BCAX | Bicara Therapeutics Inc. (BCAX) | Healthcare | 568,919.0 | $11.3M | 2.38% | — | — | $19.89 | -0.6% |
| 5 | — | BridgeBio Oncology Therapeutics (BBOT) | — | 1,018,018.0 | $9.1M | 1.91% | +453K | +80.3% | $8.95 | — |
| 6 | CMPS | Compass Pathways Plc (CMPS) | Healthcare | 1,432,336.0 | $7.9M | 1.66% | +234K | +19.5% | $5.53 | +136.7% |
| 7 | SRRK | Scholar Rock Holding Corporation (SRRK) | Healthcare | 77,031.0 | $3.8M | 0.80% | — | — | $49.16 | -1.1% |
| 8 | BMEA | Biomea Fusion Inc (BMEA) | Healthcare | 2,048,757.0 | $3.1M | 0.66% | — | — | $1.53 | -2.6% |
| 9 | — | Eupraxia Pharmaceuticals Inc. (EPRX) | — | 325,000.0 | $2.4M | 0.49% | NEW | — | $7.24 | — |
| 10 | URGN | Urogen Pharma Ltd. (URGN) | Healthcare | 108,000.0 | $1.9M | 0.41% | — | — | $17.98 | +129.3% |
| 11 | ACRS | Aclaris Therapeutics Inc (ACRS) | Healthcare | 434,455.0 | $1.6M | 0.34% | — | — | $3.75 | +43.5% |
| 12 | — | Marker Therapeutics, Inc. (MRKR) | — | 325,370.0 | $423K | 0.09% | — | — | $1.30 | — |
| 13 | — | OnKure Therapeutics, Inc. (OKUR) | — | 88,607.0 | $367K | 0.08% | — | — | $4.14 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%